Express Scripts Holding Company Company Profile (NASDAQ:ESRX)

About Express Scripts Holding Company (NASDAQ:ESRX)

Express Scripts Holding Company logoExpress Scripts, Inc. is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM). PBM segment’s services include retail network pharmacy management and retail drug card programs, home delivery services, specialty benefit services, patient care contact centers, benefit plan design and consultation, drug formulary management, compliance and therapy management programs, information reporting and analysis programs, rebate programs, and electronic claims processing and drug utilization review. EM segment’s services include distribution of pharmaceuticals and medical supplies to providers and clinics and healthcare account administration and implementation of consumer-directed healthcare solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Health Care Plans
  • Sub-Industry: Health Care Services
  • Symbol: NASDAQ:ESRX
  • CUSIP: 30219G10
  • Web: www.express-scripts.com
Capitalization:
  • Market Cap: $36.08 billion
  • Outstanding Shares: 577,549,000
Average Prices:
  • 50 Day Moving Avg: $61.81
  • 200 Day Moving Avg: $62.96
  • 52 Week Range: $57.80 - $77.50
P/E:
  • Trailing P/E Ratio: 10.81
  • Foreward P/E Ratio: 8.14
  • P/E Growth: 0.82
Sales & Book Value:
  • Annual Revenue: $100.28 billion
  • Price / Sales: 0.36
  • Book Value: $27.26 per share
  • Price / Book: 2.29
Profitability:
  • EBIDTA: $7.16 billion
  • Net Margins: 3.50%
  • Return on Equity: 25.58%
  • Return on Assets: 7.96%
Debt:
  • Debt-to-Equity Ratio: 0.88%
  • Current Ratio: 0.69%
  • Quick Ratio: 0.58%
Misc:
  • Average Volume: 3.26 million shs.
  • Beta: 0.88
  • Short Ratio: 9.82
 

Frequently Asked Questions for Express Scripts Holding Company (NASDAQ:ESRX)

What is Express Scripts Holding Company's stock symbol?

Express Scripts Holding Company trades on the NASDAQ under the ticker symbol "ESRX."

How were Express Scripts Holding Company's earnings last quarter?

Express Scripts Holding Company (NASDAQ:ESRX) announced its quarterly earnings data on Tuesday, July, 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to analysts' expectations of $25.52 billion. Express Scripts Holding Company had a return on equity of 25.58% and a net margin of 3.50%. The firm's quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.57 EPS. View Express Scripts Holding Company's Earnings History.

When will Express Scripts Holding Company make its next earnings announcement?

Express Scripts Holding Company is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for Express Scripts Holding Company.

What guidance has Express Scripts Holding Company issued on next quarter's earnings?

Express Scripts Holding Company updated its FY17 earnings guidance on Tuesday, July, 25th. The company provided earnings per share (EPS) guidance of $6.95-7.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.97. Express Scripts Holding Company also updated its Q3 guidance to $1.88-1.92 EPS.

Where is Express Scripts Holding Company's stock going? Where will Express Scripts Holding Company's stock price be in 2017?

19 equities research analysts have issued 12-month price objectives for Express Scripts Holding Company's stock. Their forecasts range from $56.00 to $85.00. On average, they expect Express Scripts Holding Company's share price to reach $68.50 in the next twelve months. View Analyst Ratings for Express Scripts Holding Company.

What are analysts saying about Express Scripts Holding Company stock?

Here are some recent quotes from research analysts about Express Scripts Holding Company stock:

  • 1. Jefferies Group LLC analysts commented, "We believe ESRX remains a Buy given our view that company fundamentals, including its FCF, are stable and that the stock's valuation is attractive at 9x FY18 P/E. That said, we recognize that headlines surrounding drug pricing pressure and the overhang from ESRX's Anthem contract will drive continued stock volatility NT." (2/17/2017)
  • 2. According to Zacks Investment Research, "Express Scripts’ fourth-quarter 2016 results were mixed, wherein adjusted earnings topped the Zacks Consensus Estimate, revenues beat the same. In the past three months, the company has underperformed the broader industry with respect to price performance. While the company’s guidance for 2017 was encouraging, tough competition in the Pharmacy Benefit Management space and the persistent drug pricing issue are expected to affect the share price. Express Scripts stands to benefit from increased generic utilization, shift toward mail orders, strong specialty growth and an aging population. The company is focused on the development of both specialty drugs and generics, which are expected to account for 50% of the total drug expenditure by 2018. Further, its SafeGuardRx suite of products is designed to better manage specialty spend in turn, establishing a higher standard for patient outcomes." (2/16/2017)
  • 3. Credit Suisse Group analysts commented, "We continue to believe ESRX will seek to buy Rite Aid’s PBM unit from Walgreens if the deal closes successfully and possibly add its generic purchasing clout to Walgreen’s buying consortium for added economics. Derivatives: At a time when hapless politicians are wringing their wrists about out of control drug costs, we cite another example of a large government payor tapping PBM solutions for greater savings. As opposed to Anthem, TRICARE utilizes a number of ESRX’s cost management tools in addition to a preferred pharmacy network to better manage its trend. We see the PBM model as more rather than less relevant to the current situation, and we see longer-term enhanced roles for PBMs in Medicare part D and B. Separately, we see AmerisourceBergen as benefiting from the news as Walgreen’s supplier, while Cardinal Health stand to lose some share as CVS’s partner." (10/3/2016)

Are investors shorting Express Scripts Holding Company?

Express Scripts Holding Company saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 33,401,117 shares, an increase of 3.9% from the August 15th total of 32,160,472 shares. Based on an average daily volume of 2,457,981 shares, the short-interest ratio is currently 13.6 days. Currently, 5.6% of the shares of the stock are short sold.

Who are some of Express Scripts Holding Company's key competitors?

Who owns Express Scripts Holding Company stock?

Express Scripts Holding Company's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (6.93%), BlackRock Inc. (6.56%), Dodge & Cox (6.27%), Capital World Investors (5.82%), State Street Corp (4.58%) and Capital Research Global Investors (2.40%). Company insiders that own Express Scripts Holding Company stock include Christopher A Mcginnis, Everett Neville, Mahon Thomas P Mac, Phyllis S Anderson and Woodrow A Myers Jr. View Institutional Ownership Trends for Express Scripts Holding Company.

Who sold Express Scripts Holding Company stock? Who is selling Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was sold by a variety of institutional investors in the last quarter, including Numeric Investors LLC, Bank of New York Mellon Corp, The Manufacturers Life Insurance Company , TIAA CREF Investment Management LLC, Capital Guardian Trust Co., Schroder Investment Management Group, Ameriprise Financial Inc. and Capital Counsel LLC NY. Company insiders that have sold Express Scripts Holding Company stock in the last year include Everett Neville, Phyllis S Anderson and Woodrow A Myers Jr. View Insider Buying and Selling for Express Scripts Holding Company.

Who bought Express Scripts Holding Company stock? Who is buying Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was purchased by a variety of institutional investors in the last quarter, including Dodge & Cox, Pzena Investment Management LLC, Northern Trust Corp, Veritas Asset Management LLP, Macquarie Group Ltd., Arrowstreet Capital Limited Partnership, Koch Industries Inc. and PGGM Investments. View Insider Buying and Selling for Express Scripts Holding Company.

How do I buy Express Scripts Holding Company stock?

Shares of Express Scripts Holding Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Express Scripts Holding Company's stock price today?

One share of Express Scripts Holding Company stock can currently be purchased for approximately $62.47.


MarketBeat Community Rating for Express Scripts Holding Company (NASDAQ ESRX)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  634 (Vote Outperform)
Underperform Votes:  422 (Vote Underperform)
Total Votes:  1,056
MarketBeat's community ratings are surveys of what our community members think about Express Scripts Holding Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Express Scripts Holding Company (NASDAQ:ESRX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Sell Ratings, 11 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.11)
Consensus Price Target: $68.50 (9.65% upside)

Analysts' Ratings History for Express Scripts Holding Company (NASDAQ:ESRX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/19/2017Royal Bank Of CanadaInitiated CoverageSector Perform -> Sector Perform$68.00HighView Rating Details
9/1/2017Robert W. BairdReiterated RatingHold$56.00MediumView Rating Details
8/29/2017Jefferies Group LLCSet Price TargetBuy$72.00LowView Rating Details
8/10/2017Morgan StanleyBoost Price TargetUnderweight$52.00 -> $57.00LowView Rating Details
7/21/2017Needham & Company LLCInitiated CoverageHold -> HoldLowView Rating Details
6/9/2017Cowen and CompanyReiterated RatingOutperform$83.00LowView Rating Details
4/26/2017Evercore ISILower Price TargetIn-Line$68.50 -> $59.00MediumView Rating Details
4/26/2017Edward JonesDowngradeBuy -> HoldHighView Rating Details
4/25/2017SunTrust Banks, Inc.Reiterated RatingBuyHighView Rating Details
4/25/2017Bank of America CorporationReiterated RatingNeutral$77.00HighView Rating Details
4/25/2017MizuhoLower Price TargetNeutral -> Neutral$76.00 -> $61.00HighView Rating Details
3/29/2017ArgusReiterated RatingHoldLowView Rating Details
3/15/2017Wells Fargo & CompanyDowngradeMarket Perform -> UnderperformLowView Rating Details
3/8/2017Leerink SwannReiterated RatingMarket Perform$75.00LowView Rating Details
2/16/2017Credit Suisse GroupReiterated RatingBuy$85.00N/AView Rating Details
2/14/2017Oppenheimer Holdings, Inc.Reiterated RatingHoldN/AView Rating Details
12/16/2016Barclays PLCReiterated RatingOverweightN/AView Rating Details
12/1/2016Sanford C. BernsteinReiterated RatingUnderperform$59.00N/AView Rating Details
11/3/2016Deutsche Bank AGUpgradeSell -> Hold$69.00 -> $70.00N/AView Rating Details
6/1/2016WedbushReiterated RatingNeutralN/AView Rating Details
5/24/2016Citigroup Inc.Reiterated RatingBuyN/AView Rating Details
4/27/2016FBR & CoLower Price TargetMkt Perform$90.00 -> $75.00N/AView Rating Details
3/18/2016William BlairReiterated RatingBuyN/AView Rating Details
2/18/2016Goldman Sachs Group IncLower Price TargetNeutral$82.00 -> $74.00N/AView Rating Details
2/17/2016Maxim GroupReiterated RatingBuy$109.00 -> $95.00N/AView Rating Details
12/23/2015BMO Capital MarketsBoost Price TargetMarket Perform$94.00N/AView Rating Details
11/29/2015J P Morgan Chase & CoReiterated RatingBuy$105.00N/AView Rating Details
(Data available from 9/26/2015 forward)

Earnings

Earnings History for Express Scripts Holding Company (NASDAQ:ESRX)
Earnings by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Earnings History by Quarter for Express Scripts Holding Company (NASDAQ ESRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$1.89N/AView Earnings Details
7/25/2017Q2 2017$1.71$1.73$25.52 billion$25.35 billionViewN/AView Earnings Details
4/24/2017Q1 17$1.32$1.33$24.95 billion$24.65 billionViewN/AView Earnings Details
2/14/2017Q4 2016$1.87$1.88$26.31 billion$24.90 billionViewListenView Earnings Details
10/25/2016Q3$1.74$1.74$25.48 billion$25.41 billionViewListenView Earnings Details
7/25/2016Q216$1.57$1.57$25.42 billion$25.20 billionViewListenView Earnings Details
4/25/2016Q1$1.22$1.22$25.20 billion$24.80 billionViewListenView Earnings Details
2/16/2016Q4$1.56$1.56$26.58 billion$26.18 billionViewListenView Earnings Details
10/27/2015Q315$1.44$1.45$26.38 million$25.22 millionViewListenView Earnings Details
7/28/2015Q215$1.40$1.44$26.13 billion$25.45 billionViewListenView Earnings Details
4/28/2015Q115$1.10$1.10$24.34 billion$24.90 billionViewListenView Earnings Details
2/23/2015Q414$1.38$1.39$25.68 billion$26.31 billionViewListenView Earnings Details
10/28/2014Q314$1.29$1.29$24.93 billion$25.78 billionViewListenView Earnings Details
7/29/2014Q214$1.22$1.23$24.42 billion$25.11 billionViewListenView Earnings Details
4/29/2014Q114$1.01$0.99$23.81 billion$23.69 billionViewListenView Earnings Details
2/20/2014Q413$1.12$1.12$25.49 billion$25.78 billionViewN/AView Earnings Details
10/25/2013Q313$1.08$1.08$25.01 billion$25.92 billionViewListenView Earnings Details
7/29/2013Q2 2013$1.10$1.12$25.51 billion$26.40 billionViewListenView Earnings Details
4/29/2013Q1 2013$0.97$0.99$25.55 billion$26.06 billionViewListenView Earnings Details
2/18/2013Q4 2012$1.04$1.05$27.24 billion$27.41 billionViewListenView Earnings Details
11/5/2012Q312$0.99$1.02$27.48 billion$27.00 billionViewN/AView Earnings Details
8/7/2012$0.82$0.88ViewN/AView Earnings Details
5/10/2012$0.77$0.73ViewN/AView Earnings Details
2/22/2012$0.85$0.82ViewN/AView Earnings Details
10/25/2011$0.77$0.79ViewN/AView Earnings Details
7/21/2011$0.69$0.71ViewN/AView Earnings Details
4/26/2011$0.69$0.66ViewN/AView Earnings Details
2/16/2011$0.70$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Express Scripts Holding Company (NASDAQ:ESRX)
2017 EPS Consensus Estimate: $6.98
2018 EPS Consensus Estimate: $7.61
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$1.31$1.33$1.32
Q2 20175$1.68$1.72$1.70
Q3 20175$1.90$1.91$1.90
Q4 20175$2.03$2.07$2.05
Q1 20183$1.45$1.52$1.48
Q2 20183$1.85$1.89$1.87
Q3 20183$2.02$2.09$2.05
Q4 20183$2.16$2.26$2.22
Q1 20191$1.59$1.59$1.59
Q2 20191$2.01$2.01$2.01
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Express Scripts Holding Company (NASDAQ:ESRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Express Scripts Holding Company (NASDAQ:ESRX)
Insider Ownership Percentage: 0.68%
Institutional Ownership Percentage: 88.69%
Insider Trades by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Institutional Ownership by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Insider Trades by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/11/2017Woodrow A Myers JrDirectorSell3,900$63.93$249,327.00View SEC Filing  
9/8/2017Phyllis S AndersonVPSell578$63.13$36,489.14View SEC Filing  
8/23/2017Everett NevilleVPSell1,163$61.48$71,501.24View SEC Filing  
5/19/2017Phyllis S AndersonVPSell1,100$60.08$66,088.00View SEC Filing  
3/1/2017Everett NevilleSVPSell2,352$70.16$165,016.32View SEC Filing  
1/3/2017Everett NevilleVPSell1,123$69.41$77,947.43View SEC Filing  
9/14/2016Woodrow A Myers JrDirectorSell12,036$70.40$847,334.40View SEC Filing  
9/12/2016Christopher A McginnisVPSell1,785$70.77$126,324.45View SEC Filing  
5/10/2016Everett NevilleVPSell800$74.11$59,288.00View SEC Filing  
4/29/2016Mahon Thomas P MacDirectorSell5,482$73.93$405,284.26View SEC Filing  
3/10/2016Christopher A McginnisVPSell579$68.56$39,696.24View SEC Filing  
3/7/2016Phyllis S AndersonVPSell614$71.14$43,679.96View SEC Filing  
2/29/2016Everett NevilleVPSell4,323$71.00$306,933.00View SEC Filing  
6/9/2015Gary WimberlyVPSell1,644$87.14$143,258.16View SEC Filing  
6/1/2015Gary WimberlyVPSell46,069$86.15$3,968,844.35View SEC Filing  
3/2/2015Glen D StettinVPSell2,674$84.39$225,658.86View SEC Filing  
2/25/2015Glen D StettinVPSell27,603$87.55$2,416,642.65View SEC Filing  
12/2/2014Keith J EblingVPSell10,000$84.25$842,500.00View SEC Filing  
12/1/2014Steven B MillerVPSell4,896$83.57$409,158.72View SEC Filing  
11/28/2014Glen D StettinVPSell10,800$82.96$895,968.00View SEC Filing  
11/17/2014John O ParkerDirectorSell25,822$78.75$2,033,482.50View SEC Filing  
11/7/2014Maura C BreenDirectorSell13,128$77.80$1,021,358.40View SEC Filing  
9/5/2014Edward B IgnaczakEVPSell9,886$75.28$744,218.08View SEC Filing  
8/28/2014Seymour SternbergDirectorSell15,508$74.12$1,149,452.96View SEC Filing  
8/25/2014Keith J EblingVPSell10,000$75.50$755,000.00View SEC Filing  
8/5/2014Gary G BenanavDirectorSell12,694$70.82$898,989.08View SEC Filing  
8/5/2014Sara E WadeVPSell20,000$70.44$1,408,800.00View SEC Filing  
8/4/2014David A NortonVPSell1,276$71.02$90,621.52View SEC Filing  
8/1/2014Maura C BreenDirectorSell12,694$69.94$887,818.36View SEC Filing  
6/13/2014George PazCEOSell681,508$71.21$48,530,184.68View SEC Filing  
3/11/2014Keith EblingVPSell25,721$78.69$2,023,985.49View SEC Filing  
3/10/2014Patrick McnameeCOOSell68,425$78.28$5,356,309.00View SEC Filing  
3/10/2014Steven MillerVPSell12,664$77.96$987,285.44View SEC Filing  
3/7/2014Keith EblingVPSell295,367$77.29$22,828,915.43View SEC Filing  
1/9/2014Nicholas LahowchicDirectorSell7,650$72.00$550,800.00View SEC Filing  
12/26/2013Nicholas LahowchicDirectorSell12,694$70.00$888,580.00View SEC Filing  
11/5/2013Mahon Thomas MacDirectorSell10,251$63.20$647,863.20View SEC Filing  
9/9/2013Maura C BreenDirectorSell10,527$64.12$674,991.24View SEC Filing  
9/4/2013Woodrow Myers, Jr.DirectorSell7,128$64.66$460,896.48View SEC Filing  
7/19/2013Nicholas LahowchicDirectorSell20,377$66.26$1,350,180.02View SEC Filing  
6/11/2013Woodrow A Myers JrDirectorSell1,750$62.57$109,497.50View SEC Filing  
5/28/2013Woodrow A Myers JrDirectorSell2,000$63.75$127,500.00View SEC Filing  
5/15/2013Jeffrey HallCFOSell13,307$61.13$813,456.91View SEC Filing  
5/8/2013Woodrow A Myers JrDirectorSell13,462$61.22$824,143.64View SEC Filing  
5/1/2013Keith J EblingEVPSell59,494$59.58$3,544,652.52View SEC Filing  
4/30/2013Patrick McnameeCOOSell271,972$59.65$16,223,129.80View SEC Filing  
3/14/2013Mahon Thomas P MacDirectorBuy5,000$59.58$297,900.00View SEC Filing  
9/4/2012Jeffrey HallCFOSell75,000$62.81$4,710,750.00View SEC Filing  
8/8/2012Edward B IgnaczakEVPSell115,466$59.33$6,850,597.78View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Express Scripts Holding Company (NASDAQ:ESRX)
Latest Headlines for Express Scripts Holding Company (NASDAQ:ESRX)
Source:
DateHeadline
finance.yahoo.com logoNovartis's $475,000 Price on Cancer Therapy Meets Resistance
finance.yahoo.com - September 22 at 8:23 AM
finance.yahoo.com logoExpress Scripts Holding Co. breached its 50 day moving average in a Bearish Manner : ESRX-US : September 19, 2017
finance.yahoo.com - September 19 at 6:23 PM
americanbankingnews.com logoRoyal Bank Of Canada Begins Coverage on Express Scripts Holding Company (ESRX)
www.americanbankingnews.com - September 19 at 7:38 AM
americanbankingnews.com logoResearch Analysts Issue Forecasts for Express Scripts Holding Company's Q1 2019 Earnings (ESRX)
www.americanbankingnews.com - September 18 at 8:00 AM
finance.yahoo.com logoWhy Express Scripts Holding Company (ESRX) Could Be A Buy
finance.yahoo.com - September 17 at 10:47 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - September 17 at 1:20 PM
americanbankingnews.com logo$25.67 Billion in Sales Expected for Express Scripts Holding Company (ESRX) This Quarter
www.americanbankingnews.com - September 15 at 5:40 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) VP Sells $36,489.14 in Stock
www.americanbankingnews.com - September 12 at 8:24 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Director Sells $249,327.00 in Stock
www.americanbankingnews.com - September 12 at 7:52 PM
finance.yahoo.com logoExpress Scripts Offers Important Prescription Drug Information for Residents Impacted by Hurricane Irma
finance.yahoo.com - September 7 at 6:31 PM
finance.yahoo.com logoExpress Scripts Holding Company Announces Third Quarter 2017 Earnings Conference Call
finance.yahoo.com - September 5 at 8:04 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Downgraded by ValuEngine
www.americanbankingnews.com - September 3 at 2:04 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Receives "Hold" Rating from Robert W. Baird
www.americanbankingnews.com - September 1 at 8:56 PM
finance.yahoo.com logoExpress Scripts Holding Co. breached its 50 day moving average in a Bullish Manner : ESRX-US : September 1, 2017
finance.yahoo.com - September 1 at 6:44 PM
barrons.com logoLoews Invests $21M in CVS; Tisch Buys GE - Barron's
www.barrons.com - August 30 at 7:42 PM
americanbankingnews.com logoJefferies Group LLC Analysts Give Express Scripts Holding Company (ESRX) a $72.00 Price Target
www.americanbankingnews.com - August 29 at 9:28 PM
nasdaq.com logoExpress Scripts to Boost Oral Medication With Diabetes Study - Nasdaq
www.nasdaq.com - August 28 at 6:08 PM
finance.yahoo.com logoExpress Scripts Is on Sale
finance.yahoo.com - August 28 at 6:08 PM
americanbankingnews.com logoZacks: Analysts Anticipate Express Scripts Holding Company (ESRX) Will Announce Quarterly Sales of $25.67 Billion
www.americanbankingnews.com - August 28 at 5:52 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Sees Large Growth in Short Interest
www.americanbankingnews.com - August 27 at 4:28 AM
finance.yahoo.com logoExpress Scripts (ESRX) Down 2.6% Since Earnings Report: Can It Rebound? - Yahoo Finance
finance.yahoo.com - August 26 at 10:50 PM
americanbankingnews.com logoEverett Neville Sells 1,163 Shares of Express Scripts Holding Company (ESRX) Stock
www.americanbankingnews.com - August 25 at 8:32 PM
finance.yahoo.com logoExpress Scripts Research Shows Significant Benefit of Adherence to Diabetes Medications
finance.yahoo.com - August 25 at 8:00 PM
zacks.com logoExpress Scripts (ESRX) Down 2.6% Since Earnings Report: Can It Rebound?
www.zacks.com - August 25 at 5:30 AM
finance.yahoo.com logoInside Rx Expands Program To More Than 60 Prescription Brand Medications; Saves Americans More Than $1 Million Since Launch
finance.yahoo.com - August 24 at 7:25 PM
finance.yahoo.com logoExpress Scripts Named a Best Place to Work for Disability Inclusion
finance.yahoo.com - August 23 at 10:55 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - August 23 at 2:58 PM
finance.yahoo.com logoRemicade Is a Litmus Test for PBMs
finance.yahoo.com - August 17 at 7:41 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Express Scripts Holding Co.
finance.yahoo.com - August 12 at 5:41 PM
nasdaq.com logoRelative Strength Alert For Express Scripts Holding - Nasdaq
www.nasdaq.com - August 10 at 7:43 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) PT Raised to $57.00 at Morgan Stanley
www.americanbankingnews.com - August 10 at 7:02 PM
americanbankingnews.com logo Brokerages Expect Express Scripts Holding Company (NASDAQ:ESRX) Will Announce Quarterly Sales of $25.77 Billion
www.americanbankingnews.com - August 10 at 5:16 PM
finance.yahoo.com logoETFs with exposure to Express Scripts Holding Co. : August 8, 2017
finance.yahoo.com - August 8 at 6:08 PM
americanbankingnews.com logo$1.90 Earnings Per Share Expected for Express Scripts Holding Company (NASDAQ:ESRX) This Quarter
www.americanbankingnews.com - August 8 at 7:32 AM
benzinga.com logoMylan Price Target Slashed Even As TLD Drug Receives Tentative Approval - Benzinga
www.benzinga.com - August 7 at 6:41 PM
finance.yahoo.com logoBehind the Push to Keep Higher-Priced EpiPen in Consumers’ Hands
finance.yahoo.com - August 6 at 10:25 PM
finance.yahoo.com logoBehind the Push to Keep Higher-Priced EpiPen in Consumers' Hands
finance.yahoo.com - August 6 at 5:20 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Lowered to "Strong Sell" at BidaskClub
www.americanbankingnews.com - August 6 at 11:20 AM
finance.yahoo.com logoExpress Scripts gave $10,000 for Gov. Greitens' inauguration
finance.yahoo.com - August 5 at 4:46 AM
nasdaq.com logoWal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals - Nasdaq
www.nasdaq.com - August 3 at 8:20 PM
seekingalpha.com logoExpress Scripts: Value And Growth
seekingalpha.com - August 3 at 3:17 PM
finance.yahoo.com logoPharma's Quieter Price War Continues
finance.yahoo.com - August 3 at 3:17 PM
finance.yahoo.com logoExpress Scripts Holding Co. breached its 50 day moving average in a Bearish Manner : ESRX-US : August 2, 2017
finance.yahoo.com - August 2 at 7:20 PM
finance.yahoo.com logoThe Value of Active Pharmacy Management: Express Scripts 2018 National Preferred Formulary
finance.yahoo.com - July 31 at 6:10 PM
finance.yahoo.com logoExpress Scripts to cover Mylan's EpiPen, exclude rivals
finance.yahoo.com - July 31 at 6:10 PM
americanbankingnews.com logoOppenheimer Holdings Research Analysts Decrease Earnings Estimates for Express Scripts Holding Company (NASDAQ:ESRX)
www.americanbankingnews.com - July 31 at 7:55 AM
americanbankingnews.com logoExpress Scripts Holding Company (NASDAQ:ESRX) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 29 at 10:39 AM
finance.yahoo.com logoExpress Scripts discloses purchase price for myMatrixx
finance.yahoo.com - July 28 at 9:28 PM
finance.yahoo.com logoDrug middleman Express Scripts is getting peppered with questions about Amazon and health care
finance.yahoo.com - July 28 at 4:27 PM
americanbankingnews.com logoFY2017 Earnings Estimate for Express Scripts Holding Company Issued By William Blair (NASDAQ:ESRX)
www.americanbankingnews.com - July 28 at 9:31 AM

Social

Chart

Express Scripts Holding Company (ESRX) Chart for Tuesday, September, 26, 2017

This page was last updated on 9/26/2017 by MarketBeat.com Staff